Holen Sie sich die Stockscreener-App
0.00
100.00%
-1.74
Schlusskurs vom Vortag:
$1.74
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$45.77M
Einnahmen:
$4.99M
Nettoeinkommen (Verlust:
$-28.29M
KGV:
0.00
EPS:
-1.0528
Netto-Cashflow:
$-36.20M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$1.825
Lava Therapeutics Nv Stock (LVTX) Company Profile
Firmenname
Lava Therapeutics Nv
Sektor
Branche
Telefon
31 6 3000 3035
Adresse
YALELAAN 62, UTRECHT
Vergleichen Sie LVTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LVTX
Lava Therapeutics Nv
|
0.00 | 45.77M | 4.99M | -28.29M | -36.20M | -1.0528 |
|
VRTX
Vertex Pharmaceuticals Inc
|
456.20 | 113.51B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
767.96 | 78.69B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.23 | 52.32B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.99 | 52.15B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
174.84 | 35.52B | 447.02M | -1.18B | -906.14M | -6.1812 |
Lava Therapeutics Nv Stock (LVTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-12 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-12-11 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2022-10-25 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-04-19 | Eingeleitet | JP Morgan | Overweight |
| 2021-04-19 | Eingeleitet | Jefferies | Buy |
| 2021-04-19 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Lava Therapeutics Nv Aktie (LVTX) Neueste Nachrichten
Will LAVA Therapeutics N.V. stock see insider buyingJuly 2025 Patterns & High Conviction Investment Ideas - Улправда
Can LAVA Therapeutics N.V. stock hit record highs againWeekly Trend Recap & Reliable Intraday Trade Alerts - DonanımHaber
Is LAVA Therapeutics N.V. (4PKB) stock worth buying before Fed actionMarket Sentiment Report & Comprehensive Market Scan Reports - DonanımHaber
How dovish Fed policy supports LAVA Therapeutics N.V. (4PKB) stockOptions Play & Weekly Watchlist for Hot Stocks - DonanımHaber
Is LAVA Therapeutics N.V. (4PKB) stock dividend growth reliableMarket Volume Summary & Momentum Based Trading Ideas - ulpravda.ru
What analysts say about LAVA Therapeutics NV 4PKB stockStock Market Trends & Zero-Cost Stock Research by Professionals - earlytimes.in
Will New Product Launches Boost Go Digit General Insurance Limiteds Revenue in YEARConsumer Goods Stocks & Free Rapid Growing Investment Returns - earlytimes.in
Published on: 2025-12-18 13:21:42 - Улправда
Volume Recap: Is LAVA Therapeutics NV 4PKB stock worth buying before Fed actionAnalyst Downgrade & Short-Term Trading Opportunity Alerts - moha.gov.vn
XOMA Royalty (Nasdaq: XOMA) completes $2.035 per share Mural Oncology takeover - Stock Titan
Total debt per share of LAVA Therapeutics NV – BER:4PKB - TradingView
Operating cash flow per share of LAVA Therapeutics NV – SWB:4PKB - TradingView
Can LAVA Therapeutics N.V. (4PKB) stock expand revenue streamsMarket Activity Recap & Daily Volume Surge Signals - Newser
Why LAVA Therapeutics N.V. (4PKB) stock is listed among top recommendations2025 Growth vs Value & Daily Stock Trend Reports - Newser
Is LAVA Therapeutics NV technically bullish or bearish? - Markets Mojo
LAVA Therapeutics (LVTX) Expected to Announce Earnings on Tuesday - Defense World
LAVA Therapeutics NV Financial Disclosures & Filings - TradingView
XOMA Royalty Announces Closing of Transactions to Acquire LAVA Therapeutics N.V. - ADVFN
XOMA Royalty completes acquisition of LAVA Therapeutics By Investing.com - Investing.com Nigeria
Lava Therapeutics shares delisted from Nasdaq following completion of acquisition - Investing.com Nigeria
Lava Therapeutics shares delisted from Nasdaq following completion of acquisition By Investing.com - Investing.com South Africa
XOMA Completes Acquisition of LAVA Therapeutics - TipRanks
[SC TO-T/A] LAVA Therapeutics NV Amended Third-Party Tender Offer | LVTX SEC FilingForm SC TO-T/A - Stock Titan
XOMA Royalty completes acquisition of LAVA Therapeutics - Investing.com
LAVA Therapeutics Announces Executive Departures - TradingView
[8-K] LAVA Therapeutics NV Reports Material Event | LVTX SEC FilingForm 8-K - Stock Titan
Xoma Royalty announces closing of transactions to acquire LAVA Therapeutics N.V. - MarketScreener
XOMA Royalty Corporation Completes Acquisition of LAVA Therapeutics N.V. - Quiver Quantitative
XOMA Royalty (Nasdaq: XOMA) completes LAVA deal; investors get $1.04 plus CVR - Stock Titan
Will LAVA Therapeutics N.V. stock benefit from AI adoption2025 Big Picture & Weekly High Return Opportunities - newser.com
What makes LAVA Therapeutics N.V. (4PKB) stock appealing to growth investorsIPO Watch & High Return Stock Watch Alerts - newser.com
EBIT per share of LAVA Therapeutics NV – MUN:4PKB - TradingView
LAVA Therapeutics N.V.(NasdaqGS: LVTX) dropped from NASDAQ Composite Index - MarketScreener
How LAVA Therapeutics N.V. (4PKB) stock expands through international markets2025 Breakouts & Breakdowns & Weekly Chart Analysis and Trade Guides - newser.com
How LAVA Therapeutics N.V. (4PKB) stock trades in high volatilityChart Signals & Proven Capital Preservation Tips - newser.com
How LAVA Therapeutics N.V. stock performs during Fed tightening cyclesQuarterly Earnings Report & AI Based Buy/Sell Signal Reports - newser.com
Will LAVA Therapeutics N.V. (4PKB) stock outperform small cap peersMarket Performance Report & Verified Stock Trade Ideas - newser.com
LAVA Therapeutics NV (4PKB.MU) Latest Press Releases & Corporate News - Yahoo! Finance Canada
Will LAVA Therapeutics N.V. (4PKB) stock justify high valuationWeekly Profit Report & Expert Curated Trade Setup Alerts - newser.com
Why hedge funds are buying LAVA Therapeutics N.V. stockJuly 2025 Setups & Entry Point Confirmation Signals - newser.com
Advanced analytics toolkit walkthrough for LAVA Therapeutics N.V.Sell Signal & High Yield Stock Recommendations - newser.com
Will LAVA Therapeutics N.V. stock benefit from green energy trendsWall Street Watch & Expert Curated Trade Ideas - newser.com
How to track smart money flows in LAVA Therapeutics N.V.2025 Winners & Losers & Daily Profit Focused Screening - newser.com
Is LAVA Therapeutics N.V. showing signs of accumulationWall Street Watch & Reliable Intraday Trade Alerts - newser.com
How LAVA Therapeutics N.V. stock valuations compare to rivals2025 Trade Ideas & Technical Confirmation Trade Alerts - newser.com
Why LAVA Therapeutics N.V. (4PKB) stock stays on buy listsWeekly Trade Analysis & Safe Swing Trade Setups - newser.com
Finanzdaten der Lava Therapeutics Nv-Aktie (LVTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.44%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):